Brookfield’s global head of private equity, Anuj Ranjan, believes that rising private credit activity is complementing — not displacing — traditional private equity buy-outs, according to a report by Bloomberg.
Chinese private equity firm Boyu Capital is leading the race to acquire a controlling stake in Starbucks’ China operations, in a deal that could value the business at more than $4bn, according to a report by Bloomberg.
Blackstone Inc is partnering with Saudi Arabia’s AI company Humain to develop data centres across the kingdom, beginning with an initial $3bn investment, marking a significant step in the region’s AI infrastructure ambitions, according to a report by Bloomberg.
Medline Inc, the US medical supplies business taken private in a $34bn leveraged buyout by Blackstone, Carlyle Group, and Hellman & Friedman in 2021, has publicly filed for an IPO, setting the stage for one of the largest-ever PE -backed listings.
Sweden-based private-markets firm EQT AB is aiming to more than double its European investments — raising them from roughly €120bn over the last five years, to €250bn over the next five — according to a report by Reuters.
Global investment firm Permira has realised its investment in Nexthink, a developer of Digital Employee Experience management software. The all-cash transaction, which values the business at around $3bn sees Vista Equity Partners acquire a majority holding.
Peter Stefanski, a veteran of Thoma Bravo, has joined Nexa Equity as a partner to bolster the firm’s focus on AI-driven investments, according to a report by Reuters. Stefanski spent 14 years at Thoma Bravo, including time working as a partner on the firm’s flagship fund.
Diversis Capital, a lower mid-market software and technology-focused private equity firm, has closed its third fund at $1.2bn, exceeding the initial $850m target and nearly doubling the size of its 2021 Fund II, which raised $680m, according to a report by Buyouts Insider.
UK-based private equity firm Cinven is weighing a potential exit for German software company Think‑cell, with the business possibly being marketed at a valuation of up to €3bn ($3.5bn), according to a report by Bloomberg.
Blackstone Inc is deploying more than $1bn in private credit to refinance loans tied to clinical trial software company Signant Health, according to a report by Bloomberg. The investment company will reportedly hold more than half the total debt, with other direct lenders joining in the future.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
